What are clinically relevant dissolution specifications?

First Page		Document Content
Clinical research Bioequivalence Pharmacokinetics In vivo Food and Drug Administration Dissolution testing IVIVC Pharmaceutical sciences Pharmacology Research		What are clinically relevant dissolution specifications? Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 948,71 KB Share Document on Facebook

	© World Health Organization WHO Technical Report Series, No. 937, 2006 Annex 7 Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish DocID: 18wkU - View Document
	FY 2013 Awarded GDUFA Regulatory Research Contracts and Grants FY2014 Extension or Expansion Development of In Vivo Predictive Dissolution Method for Orally Inhaled Drug Products • Multiple Awards to: University of Bat DocID: KfMA - View Document
	Use and Limitations of In Vitro Dissolution Testing: Topic Introduction and Overview DocID: E7bZ - View Document
	Biopharmaceutics Risk of OrallyAdministered Products FY 2014 GDUFA Regulatory Science Initiatives Part 15 Public Meeting Silver Spring, MD James E. Polli and Tricia Ting DocID: BpQF - View Document
	Biorelevant In-Vitro Release Testing of NonOral Dosage Forms – FDA Perspectives Tapash Ghosh, Ph.D Team Leader, Biopharmaceutics, ONDQA, FDA Annual AAPS, San Antonio, Texas November 11, 2013 Disclaimer: The contents of DocID: z8y7 - View Document